Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 37 entries
Sorted by: Best Match Show Resources per page
Compliance with the main preventive measures of COVID-19 in Spain: The role of knowledge, attitudes, practices, and risk perception.

Transboundary and emerging diseases

Beca-Martínez MT, Romay-Barja M, Falcón-Romero M, Rodríguez-Blázquez C, Benito-Llanes A, Forjaz MJ.
PMID: 34730277
Transbound Emerg Dis. 2021 Nov 03; doi: 10.1111/tbed.14364. Epub 2021 Nov 03.

In epidemics such as COVID-19, major changes need to be made to the population's behavior to prevent infection and stop disease transmission. The three most recommended preventive measures are wearing a mask, washing hands with soap or hydroalcoholic gel,...

Cite
Beca-Martínez MT, Romay-Barja M, Falcón-Romero M, et al. Compliance with the main preventive measures of COVID-19 in Spain: The role of knowledge, attitudes, practices, and risk perception. Transbound Emerg Dis. 2021;doi: 10.1111/tbed.14364.
Beca-Martínez, M. T., Romay-Barja, M., Falcón-Romero, M., Rodríguez-Blázquez, C., Benito-Llanes, A., & Forjaz, M. J. (2021). Compliance with the main preventive measures of COVID-19 in Spain: The role of knowledge, attitudes, practices, and risk perception. Transboundary and emerging diseases, . https://doi.org/10.1111/tbed.14364
Beca-Martínez, María Teresa, et al. "Compliance with the main preventive measures of COVID-19 in Spain: The role of knowledge, attitudes, practices, and risk perception." Transboundary and emerging diseases vol. (2021). doi: https://doi.org/10.1111/tbed.14364
Beca-Martínez MT, Romay-Barja M, Falcón-Romero M, Rodríguez-Blázquez C, Benito-Llanes A, Forjaz MJ. Compliance with the main preventive measures of COVID-19 in Spain: The role of knowledge, attitudes, practices, and risk perception. Transbound Emerg Dis. 2021 Nov 03; doi: 10.1111/tbed.14364. Epub 2021 Nov 03. PMID: 34730277; PMCID: PMC8661801.
Copy Download .nbib Format: NLM
Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Ayala A, Forjaz MJ, Ramallo-Fariña Y, Martín-Fernández J, García-Pérez L, Bilbao A.
PMID: 34119086
Value Health. 2021 Jun;24(6):874-883. doi: 10.1016/j.jval.2021.01.003. Epub 2021 Mar 31.

OBJECTIVES: The mapping technique can estimate generic preference-based measure scores through a specific measure that cannot be used in economic evaluations. This study compared 2 response mapping methods to estimate EQ-5D-5L scores using the Western Ontario McMaster Universities Osteoarthritis...

Cite
Ayala A, Forjaz MJ, Ramallo-Fariña Y, et al. Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis. Value Health. 2021;24(6):874-883doi: 10.1016/j.jval.2021.01.003.
Ayala, A., Forjaz, M. J., Ramallo-Fariña, Y., Martín-Fernández, J., García-Pérez, L., & Bilbao, A. (2021). Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 24(6), 874-883. https://doi.org/10.1016/j.jval.2021.01.003
Ayala, Alba, et al. "Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 24,6 (2021): 874-883. doi: https://doi.org/10.1016/j.jval.2021.01.003
Ayala A, Forjaz MJ, Ramallo-Fariña Y, Martín-Fernández J, García-Pérez L, Bilbao A. Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis. Value Health. 2021 Jun;24(6):874-883. doi: 10.1016/j.jval.2021.01.003. Epub 2021 Mar 31. PMID: 34119086.
Copy Download .nbib Format: NLM
Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients.

Frontiers in pharmacology

Guerrero-Fernández de Alba I, Orlando V, Monetti VM, Mucherino S, Gimeno-Miguel A, Vaccaro O, Forjaz MJ, Poblador Plou B, Prados-Torres A, Riccardi G, Menditto E.
PMID: 33746740
Front Pharmacol. 2020 Nov 30;11:586187. doi: 10.3389/fphar.2020.586187. eCollection 2020.

No abstract available.

Cite
Guerrero-Fernández de Alba I, Orlando V, Monetti VM, et al. Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients. Front Pharmacol. 2020;11:586187doi: 10.3389/fphar.2020.586187.
Guerrero-Fernández de Alba, I., Orlando, V., Monetti, V. M., Mucherino, S., Gimeno-Miguel, A., Vaccaro, O., Forjaz, M. J., Poblador Plou, B., Prados-Torres, A., Riccardi, G., & Menditto, E. (2020). Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients. Frontiers in pharmacology, 11586187. https://doi.org/10.3389/fphar.2020.586187
Guerrero-Fernández de Alba, Inmaculada, et al. "Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients." Frontiers in pharmacology vol. 11 (2020): 586187. doi: https://doi.org/10.3389/fphar.2020.586187
Guerrero-Fernández de Alba I, Orlando V, Monetti VM, Mucherino S, Gimeno-Miguel A, Vaccaro O, Forjaz MJ, Poblador Plou B, Prados-Torres A, Riccardi G, Menditto E. Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients. Front Pharmacol. 2020 Nov 30;11:586187. doi: 10.3389/fphar.2020.586187. eCollection 2020. PMID: 33746740; PMCID: PMC7970761.
Copy Download .nbib Format: NLM
Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors?.

Sexual medicine

Carvalheira A, Forjaz V, Pereira NM.
PMID: 25356304
Sex Med. 2014 Jun;2(2):96-102. doi: 10.1002/sm2.31.

INTRODUCTION: The high effectiveness of phosphodiesterase type 5 inhibitors (PDE5-i) in the treatment of erectile dysfunction (ED) has been demonstrated. However, previous research shows that PDE5-i treatments have high discontinuation rates.AIM: The main goals of this study were to...

Cite
Carvalheira A, Forjaz V, Pereira NM. Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors?. Sex Med. 2014;2(2):96-102doi: 10.1002/sm2.31.
Carvalheira, A., Forjaz, V., & Pereira, N. M. (2014). Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors?. Sexual medicine, 2(2), 96-102. https://doi.org/10.1002/sm2.31
Carvalheira, Ana, et al. "Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors?." Sexual medicine vol. 2,2 (2014): 96-102. doi: https://doi.org/10.1002/sm2.31
Carvalheira A, Forjaz V, Pereira NM. Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors?. Sex Med. 2014 Jun;2(2):96-102. doi: 10.1002/sm2.31. PMID: 25356304; PMCID: PMC4184679.
Copy Download .nbib Format: NLM
Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Martinez P, Rodriguez-Blazquez C, Paz S, Lizán L, Forjaz MJ, Frades B, Moreno R.
PMID: 27200925
Value Health. 2014 Nov;17(7):A395. doi: 10.1016/j.jval.2014.08.883. Epub 2014 Oct 26.

No abstract available.

Cite
Martinez P, Rodriguez-Blazquez C, Paz S, et al. Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain. Value Health. 2014;17(7):A395doi: 10.1016/j.jval.2014.08.883.
Martinez, P., Rodriguez-Blazquez, C., Paz, S., Lizán, L., Forjaz, M. J., Frades, B., & Moreno, R. (2014). Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A395. https://doi.org/10.1016/j.jval.2014.08.883
Martinez, P, et al. "Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A395. doi: https://doi.org/10.1016/j.jval.2014.08.883
Martinez P, Rodriguez-Blazquez C, Paz S, Lizán L, Forjaz MJ, Frades B, Moreno R. Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain. Value Health. 2014 Nov;17(7):A395. doi: 10.1016/j.jval.2014.08.883. Epub 2014 Oct 26. PMID: 27200925.
Copy Download .nbib Format: NLM
Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline.

Frontiers in neurology

Ayala A, Triviño-Juárez JM, Forjaz MJ, Rodríguez-Blázquez C, Rojo-Abuin JM, Martínez-Martín P.
PMID: 29163328
Front Neurol. 2017 Oct 30;8:551. doi: 10.3389/fneur.2017.00551. eCollection 2017.

OBJECTIVE: The aim of this study is to present a predictive model of Parkinson's disease (PD) global severity, measured with the Clinical Impression of Severity Index for Parkinson's Disease (CISI-PD).METHODS: This is an observational, longitudinal study with annual follow-up...

Cite
Ayala A, Triviño-Juárez JM, Forjaz MJ, et al. Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline. Front Neurol. 2017;8:551doi: 10.3389/fneur.2017.00551.
Ayala, A., Triviño-Juárez, J. M., Forjaz, M. J., Rodríguez-Blázquez, C., Rojo-Abuin, J. M., & Martínez-Martín, P. (2017). Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline. Frontiers in neurology, 8551. https://doi.org/10.3389/fneur.2017.00551
Ayala, Alba, et al. "Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline." Frontiers in neurology vol. 8 (2017): 551. doi: https://doi.org/10.3389/fneur.2017.00551
Ayala A, Triviño-Juárez JM, Forjaz MJ, Rodríguez-Blázquez C, Rojo-Abuin JM, Martínez-Martín P. Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline. Front Neurol. 2017 Oct 30;8:551. doi: 10.3389/fneur.2017.00551. eCollection 2017. PMID: 29163328; PMCID: PMC5674937.
Copy Download .nbib Format: NLM
Benefits and Costs of Digital Consulting in Clinics Serving Young People With Long-Term Conditions: Mixed-Methods Approach.

JMIR medical informatics

Kim SW, Madan J, Dritsaki M, Bryce C, Forjaz V, Fraser J, Griffiths F, Hamilton K, Huxley C, Sturt J.
PMID: 30377145
JMIR Med Inform. 2018 Oct 30;6(4):e48. doi: 10.2196/medinform.9577.

BACKGROUND: Since the introduction of digital health technologies in National Health Service (NHS), health professionals are starting to use email, text, and other digital methods to consult with their patients in a timely manner. There is lack of evidence...

Cite
Kim SW, Madan J, Dritsaki M, et al. Benefits and Costs of Digital Consulting in Clinics Serving Young People With Long-Term Conditions: Mixed-Methods Approach. JMIR Med Inform. 2018;6(4):e48doi: 10.2196/medinform.9577.
Kim, S. W., Madan, J., Dritsaki, M., Bryce, C., Forjaz, V., Fraser, J., Griffiths, F., Hamilton, K., Huxley, C., & Sturt, J. (2018). Benefits and Costs of Digital Consulting in Clinics Serving Young People With Long-Term Conditions: Mixed-Methods Approach. JMIR medical informatics, 6(4), e48. https://doi.org/10.2196/medinform.9577
Kim, Sung Wook, et al. "Benefits and Costs of Digital Consulting in Clinics Serving Young People With Long-Term Conditions: Mixed-Methods Approach." JMIR medical informatics vol. 6,4 (2018): e48. doi: https://doi.org/10.2196/medinform.9577
Kim SW, Madan J, Dritsaki M, Bryce C, Forjaz V, Fraser J, Griffiths F, Hamilton K, Huxley C, Sturt J. Benefits and Costs of Digital Consulting in Clinics Serving Young People With Long-Term Conditions: Mixed-Methods Approach. JMIR Med Inform. 2018 Oct 30;6(4):e48. doi: 10.2196/medinform.9577. PMID: 30377145; PMCID: PMC6234335.
Copy Download .nbib Format: NLM
EpiGraph: an open-source platform to quantify epithelial organization.

Bioinformatics (Oxford, England)

Vicente-Munuera P, Gómez-Gálvez P, Tetley RJ, Forja C, Tagua A, Letrán M, Tozluoglu M, Mao Y, Escudero LM.
PMID: 31544932
Bioinformatics. 2020 Feb 15;36(4):1314-1316. doi: 10.1093/bioinformatics/btz683.

SUMMARY: Here we present EpiGraph, an image analysis tool that quantifies epithelial organization. Our method combines computational geometry and graph theory to measure the degree of order of any packed tissue. EpiGraph goes beyond the traditional polygon distribution analysis,...

Cite
Vicente-Munuera P, Gómez-Gálvez P, Tetley RJ, et al. EpiGraph: an open-source platform to quantify epithelial organization. Bioinformatics. 2020;36(4):1314-1316doi: 10.1093/bioinformatics/btz683.
Vicente-Munuera, P., Gómez-Gálvez, P., Tetley, R. J., Forja, C., Tagua, A., Letrán, M., Tozluoglu, M., Mao, Y., & Escudero, L. M. (2020). EpiGraph: an open-source platform to quantify epithelial organization. Bioinformatics (Oxford, England), 36(4), 1314-1316. https://doi.org/10.1093/bioinformatics/btz683
Vicente-Munuera, Pablo, et al. "EpiGraph: an open-source platform to quantify epithelial organization." Bioinformatics (Oxford, England) vol. 36,4 (2020): 1314-1316. doi: https://doi.org/10.1093/bioinformatics/btz683
Vicente-Munuera P, Gómez-Gálvez P, Tetley RJ, Forja C, Tagua A, Letrán M, Tozluoglu M, Mao Y, Escudero LM. EpiGraph: an open-source platform to quantify epithelial organization. Bioinformatics. 2020 Feb 15;36(4):1314-1316. doi: 10.1093/bioinformatics/btz683. PMID: 31544932; PMCID: PMC7703762.
Copy Download .nbib Format: NLM
[Design and validation of an oral health questionnaire for preoperative anaesthetic evaluation].

Revista brasileira de anestesiologia

Ruíz-López Del Prado G, Blaya-Nováková V, Saz-Parkinson Z, Álvarez-Montero ÓL, Ayala A, Muñoz-Moreno MF, Forjaz MJ.
PMID: 27692805
Rev Bras Anestesiol. 2017 Jan - Feb;67(1):6-14. doi: 10.1016/j.bjan.2016.09.006. Epub 2016 Sep 29.

BACKGROUND AND OBJECTIVES: Dental injuries incurred during endotracheal intubation are more frequent in patients with previous oral pathology. The study objectives were to develop an oral health questionnaire for preanaesthesia evaluation, easy to apply for personnel without special dental...

Cite
Ruíz-López Del Prado G, Blaya-Nováková V, Saz-Parkinson Z, et al. Projeto e validação de um questionário de saúde oral para avaliação pré‐anestésica no pré‐operatório. [Design and validation of an oral health questionnaire for preoperative anaesthetic evaluation]. Rev Bras Anestesiol. 2016;67(1):6-14doi: 10.1016/j.bjan.2016.09.006.
Ruíz-López Del Prado, G., Blaya-Nováková, V., Saz-Parkinson, Z., Álvarez-Montero, �. �. L., Ayala, A., Muñoz-Moreno, M. F., & Forjaz, M. J. (2017). Projeto e validação de um questionário de saúde oral para avaliação pré‐anestésica no pré‐operatório. [Design and validation of an oral health questionnaire for preoperative anaesthetic evaluation]. Revista brasileira de anestesiologia, 67(1), 6-14. https://doi.org/10.1016/j.bjan.2016.09.006
Ruíz-López Del Prado, Gema, et al. "Projeto e validação de um questionário de saúde oral para avaliação pré‐anestésica no pré‐operatório." [Design and validation of an oral health questionnaire for preoperative anaesthetic evaluation]. Revista brasileira de anestesiologia vol. 67,1 (2017): 6-14. doi: https://doi.org/10.1016/j.bjan.2016.09.006
Ruíz-López Del Prado G, Blaya-Nováková V, Saz-Parkinson Z, Álvarez-Montero ÓL, Ayala A, Muñoz-Moreno MF, Forjaz MJ. Projeto e validação de um questionário de saúde oral para avaliação pré‐anestésica no pré‐operatório. [Design and validation of an oral health questionnaire for preoperative anaesthetic evaluation]. Rev Bras Anestesiol. 2017 Jan - Feb;67(1):6-14. doi: 10.1016/j.bjan.2016.09.006. Epub 2016 Sep 29. Portuguese. PMID: 27692805.
Copy Download .nbib Format: NLM
Resistance training with instability in multiple system atrophy: a case report.

Journal of sports science & medicine

Silva-Batista C, Kanegusuku H, Roschel H, Souza EO, Cunha TF, Laurentino GC, Manoel N, De Mello MT, Piemonte ME, Brum PC, Forjaz CL, Tricoli V, Ugrinowitsch C.
PMID: 25177187
J Sports Sci Med. 2014 Sep 01;13(3):597-603. eCollection 2014 Sep.

This case report assessed quality of life, activities of daily living, motor symptoms, functional ability, neuromuscular parameters and mRNA expression of selected genes related to muscle protein synthesis and degradation in a patient with Multiple System Atrophy (MSA). The...

Cite
Silva-Batista C, Kanegusuku H, Roschel H, et al. Resistance training with instability in multiple system atrophy: a case report. J Sports Sci Med. 2014;13(3):597-603
Silva-Batista, C., Kanegusuku, H., Roschel, H., Souza, E. O., Cunha, T. F., Laurentino, G. C., Manoel, N., De Mello, M. T., Piemonte, M. E., Brum, P. C., Forjaz, C. L., Tricoli, V., & Ugrinowitsch, C. (2014). Resistance training with instability in multiple system atrophy: a case report. Journal of sports science & medicine, 13(3), 597-603.
Silva-Batista, Carla, et al. "Resistance training with instability in multiple system atrophy: a case report." Journal of sports science & medicine vol. 13,3 (2014): 597-603.
Silva-Batista C, Kanegusuku H, Roschel H, Souza EO, Cunha TF, Laurentino GC, Manoel N, De Mello MT, Piemonte ME, Brum PC, Forjaz CL, Tricoli V, Ugrinowitsch C. Resistance training with instability in multiple system atrophy: a case report. J Sports Sci Med. 2014 Sep 01;13(3):597-603. eCollection 2014 Sep. PMID: 25177187; PMCID: PMC4126297.
Copy Download .nbib Format: NLM
Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Movement disorders clinical practice

Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT.
PMID: 30363393
Mov Disord Clin Pract. 2018 Jan 03;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018.

Motor symptoms are a major feature of Huntington's disease (HD). The International Parkinson and Movement Disorder Society (MDS) commissioned the assessment of the clinimetric properties of motor rating scales in HD to make recommendations regarding their use, following previously...

Cite
Mestre TA, Forjaz MJ, Mahlknecht P, et al. Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018;5(2):111-117doi: 10.1002/mdc3.12571.
Mestre, T. A., Forjaz, M. J., Mahlknecht, P., Cardoso, F., Ferreira, J. J., Reilmann, R., Sampaio, C., Goetz, C. G., Cubo, E., Martinez-Martin, P., Stebbins, G. T. (2018). Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations. Movement disorders clinical practice, 5(2), 111-117. https://doi.org/10.1002/mdc3.12571
Mestre, Tiago A, et al. "Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations." Movement disorders clinical practice vol. 5,2 (2018): 111-117. doi: https://doi.org/10.1002/mdc3.12571
Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT. Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018 Jan 03;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018. PMID: 30363393; PMCID: PMC6174417.
Copy Download .nbib Format: NLM
Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19.

medRxiv : the preprint server for health sciences

Piras IS, Huentelman MJ, Walker JE, Arce R, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Suszczewicz KE, Borja CL, Desforges M, Deture M, Dickson DW, Beach TG, Serrano GE.
PMID: 34545375
medRxiv. 2021 Sep 15; doi: 10.1101/2021.09.12.21263291.

In this study we conducted RNA sequencing on two brain regions (olfactory bulb and amygdala) from subjects who died from COVID-19 or who died of other causes. We found several-fold more transcriptional changes in the olfactory bulb than in...

Cite
Piras IS, Huentelman MJ, Walker JE, et al. Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19. medRxiv. 2021;doi: 10.1101/2021.09.12.21263291.
Piras, I. S., Huentelman, M. J., Walker, J. E., Arce, R., Glass, M. J., Vargas, D., Sue, L. I., Intorcia, A. J., Nelson, C. M., Suszczewicz, K. E., Borja, C. L., Desforges, M., Deture, M., Dickson, D. W., Beach, T. G., & Serrano, G. E. (2021). Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.09.12.21263291
Piras, Ignazio S, et al. "Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.09.12.21263291
Piras IS, Huentelman MJ, Walker JE, Arce R, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Suszczewicz KE, Borja CL, Desforges M, Deture M, Dickson DW, Beach TG, Serrano GE. Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19. medRxiv. 2021 Sep 15; doi: 10.1101/2021.09.12.21263291. PMID: 34545375; PMCID: PMC8452114.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 37 entries